Latest studies
Every paper our editors flag with a plain-language note and an evidence rating. Filter by evidence, species, or design to find what actually applies to you.
- Study · Melanotan IIWeak / none
Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use.
This single case report describes multiple in-situ melanomas in a patient with several concurrent exposures, including melanotan, tanning beds, and anabolic hormones. With multiple confounding factors and a sample of one, it cannot attribute causation to any single agent. Relevant to the safety discussion around unregulated melanotan use, with appropriate caution about what a case report can show.
JAAD case reportsn=—HumanJul 1, 2026 - Study · Melanotan IIWeak / none
Unregulated Melanotan Use Promoted via Social Media: Emerging Dermatologic and Public Health Risks.
This short commentary raises concern about social-media promotion of unregulated melanotan and the associated dermatologic and public-health risks. It is opinion and awareness-oriented rather than a data study, but it is directly on-topic for the melanotan safety and access narrative. Useful context for the risks of the unregulated market.
International journal of dermatologyn=——Jun 1, 2026